Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7751098 | 0.90 | KMT2A (0.49) | KMT2AMEN1RAB9ANPC1POLB | |
| SCHEMBL19353009 | 0.85 | KMT2A (0.51) | KMT2APIK3CDTSHRMEN1PKM | |
| SCHEMBL18893367 | 0.82 | KMT2A (0.49) | KMT2APIK3CDTSHRMEN1PKM | |
| SCHEMBL13811574 | 0.81 | PIK3CD (0.48) | KMT2APIK3CDTSHRBRD4BRD2 | |
| SCHEMBL12750454 | 0.80 | KMT2A (0.57) | KMT2APIK3CDTSHRMEN1PKM | |
| SCHEMBL1918653 | 0.79 | KMT2A (0.65) | KMT2APIK3CDTSHRMEN1PKM | |
| SCHEMBL4396522 | 0.79 | KMT2A (0.59) | KMT2APIK3CDTSHRMEN1PKM | |
| SCHEMBL20940075 | 0.78 | KMT2A (0.45) | KMT2APIK3CDTSHRMEN1RAB9A | |
| SCHEMBL21790412 | 0.78 | KMT2A (0.45) | KMT2APIK3CDTSHRMEN1RAB9A | |
| SCHEMBL25547185 | 0.77 | KMT2A (0.66) | KMT2ATSHRMEN1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11458433-B2 | Absorbent and process for selectively removing hydrogen sulfide | BASF SE (DE) | 2022-10-04 | — | — | US | claimed |
| CN-111093803-B | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2022-06-24 | — | — | CN | claimed |
| EP-3678756-B1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2021-06-30 | — | — | EP | claimed |
| US-20200269187-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2020-08-27 | — | — | US | claimed |
| EP-3678756-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2020-07-15 | — | — | EP | claimed |
| CN-111093803-A | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2020-05-01 | — | — | CN | claimed |
| WO-2019043099-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2019-03-07 | — | — | WO | claimed |
| EP-4713117-A1 | METHOD FOR PRODUCING A DEACIDIFIED FLUID STREAM, APPARATUS FOR DEACIDIFYING A FLUID STREAM AND USE OF HEAT PUMPS FOR DEACIDIFYING A FLUID STREAM | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4713116-A1 | METHOD FOR PRODUCING A DEACIDIFIED FLUID STREAM AND AN APPARATUS FOR DEACIDIFYING A FLUID STREAM | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4713115-A1 | METHOD FOR PRODUCING A DEACIDIFIED FLUID STREAM, APPARATUS FOR DEACIDIFYING A FLUID STREAM AND USE OF HEAT PUMPS FOR DEACIDIFYING A FLUID STREAM | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-20250339809-A1 | Acid Gas Scrubbing Methods Featuring Amine Phase Separation for Hydrogen Sulfide Capture | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2025-11-06 | — | — | US | disclosed |
| US-12325004-B2 | Acid gas scrubbing methods featuring amine phase separation for hydrogen sulfide capture | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2025-06-10 | — | — | US | disclosed |
| WO-2025040491-A1 | METHOD AND APPARATUS FOR THE MANUFACTURE OF A TREATED GAS WITH REDUCED SOLVENT LOSSES | BASF SE (DE) | 2025-02-27 | — | — | WO | disclosed |
| US-7906529-B2 | Benzene, pyridine, and pyridazine derivatives | SERENEX, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20110034529-A1 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES | SERENEX, INC. (US) | 2011-02-10 | — | — | US | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090163493-A9 | cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor | SERENEX, INC. | 2009-06-25 | — | — | US | disclosed |
| US-20080096887-A1 | cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor | SERENEX, INC. | 2008-04-24 | — | — | US | disclosed |
| US-7358370-B2 | Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide | SERENEX, INC. (US) | 2008-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163493-A9 | cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor | HSP90AA1, HSP90AB1, HSPA4 | KMT2A 4225/4885PIK3CD 2703/4885TSHR 3710/4885 |
| US-20080096887-A1 | cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor | HSP90AA1, HSP90AB1, HSPA4 | KMT2A 4225/4885PIK3CD 2703/4885TSHR 3710/4885 |
| US-20110034529-A1 | BENZENE, PYRIDINE, AND PYRIDAZINE DERIVATIVES | CDK4, P2RX4, MKI67 | KMT2A 3443/4885PIK3CD 2514/4885TSHR 1413/4885 |
| US-20090281292-A1 | 10a-Azalide Compound | IL17A, AZI2, HDAC9 | KMT2A 939/4885PIK3CD 3870/4885TSHR 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.